Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27144769.
- Also identified by DOI 10.1371/journal.pone.0154857 and PMC identifier 4856382.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
BACKGROUND: Hemophilia A animal models have helped advance our understanding of factor VIII deficiency. Previously, factor VIII deficient mouse models were reported to have a normal life span without spontaneous bleeds. However, the bleeding frequency and survival in these animals has not been thoroughly evaluated. OBJECTIVE: To investigate the survival and lethal bleeding frequency in two strains of E-16 hemophilia A mice. METHODS: We prospectively studied factor VIII deficient hemizygous affected males (n = 83) and homozygous affected females (n = 55) for survival and bleeding frequency. Animals were evaluated for presence and location of bleeds as potential cause of death. RESULTS AND CONCLUSIONS: Hemophilia A mice had a median survival of 254 days, which is significantly shortened compared to wild type controls (p < 0.0001). In addition, the hemophilia A mice experienced hemorrhage in several tissues. This previously-underappreciated shortened survival in the hemophilia A murine model provides new outcomes for investigation of therapeutics and also reflects the shortened lifespan of patients if left untreated.
Medical subject headings
- Hemophilia A
- Hemorrhage